Antimicrobial Agents and Chemotherapy, volume 65, issue 5
Nybomycin inhibits both fluoroquinolone-sensitive and fluoroquinolone-resistant escherichia coli DNA gyrase
Alina A. Sofronova
2
,
Ekaterina A Berdnikovich
2
,
Ekaterina S. Komarova
2, 4
,
Valeriya I Marina
1, 5
,
Tinashe P Maviza
3
,
Yan A Ivanenkov
7, 8
,
Petr V. Sergiev
1, 3, 4, 9
,
Ilya A Osterman
1, 3
,
Olga A. Dontsova
1, 3, 9, 10
9
Publication type: Journal Article
Publication date: 2021-04-19
scimago Q1
wos Q1
SJR: 1.357
CiteScore: 10.0
Impact factor: 4.1
ISSN: 00664804, 10986596
PubMed ID:
33593838
Pharmacology
Infectious Diseases
Pharmacology (medical)
Abstract
Bacterial type II topoisomerases, DNA gyrase and topoisomerase IV, are targets of many antibiotics, including fluoroquinolones (FQs). Unfortunately, a number of bacterial species easily acquire resistance to FQs by mutations in either DNA gyrase or topoisomerase IV genes.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.